ApplicationNo. 594094 filed on 10/09/1990
US Classes:424/427, Ocular424/422, Implant or insert514/8, Glycoprotein (carbohydrate containing)514/912, OPHTHALMIC514/914, Inflammation514/915, Wetting agent530/395, Glycoprotein, e.g., mucins proteoglycans, etc.530/830Plasma; serum
ExaminersPrimary: Page, Thurman K.
Assistant: Azpuru, Carlos
Attorney, Agent or Firm
Foreign Patent References
International ClassesC07K 001/02
Foreign Application Priority Data1989-02-13 JP
AbstractVitronectin produces very high therapeutic effects upon injuries of the corneal epithelium. When applied to lesions of the corneal epithelium in the form of eye drops, Vitronectin induces rapid cure of the lesions with regeneration of normal cells. Moreover Vitronectin can be sterilized by autoclaving.